Healthcare providers of all types face the temptation to consolidate. The pitch goes something like this: Contract with or sell to a corporate enterprise and stop swimming against a current that favors large conglomerates. Turn over...
– By Jennifer Waters, SVP, Retina. Growth is supposed to make a company better. More customers. More employees. More resources. More market power. Yet growth can also erode the very thing that made a company successful: its ability...
BioCareSD®, a national specialty drug distributor with nearly 50 years of experience delivering life-saving and life-changing therapies through high-touch service and a differentiated distribution model, and AllyGPO®, a leading innovator and next-generation specialty group purchasing organization...
AllyGPO®, a leading innovator and next-generation specialty group purchasing organization (GPO), and BioCareSD®, a national specialty distributor with nearly 50 years of experience delivering high-touch specialty drug distribution services, today announced that Utah Cancer Specialists, one...
A leading innovator and next-generation specialty group purchasing organization (GPO), and BioCareSD®, a national specialty drug distributor with nearly 50 years of experience delivering life‑saving therapies through high‑touch service and a differentiated distribution model, today announced...
– By Jennifer Waters, SVP, Retina. Why Retina Practices Need Clear Line of Sight Into Every Dollar of “Savings” In today’s retina distribution landscape, pricing can look clean and simple on the surface—one neat “net price,” often positioned...
– By Jennifer Waters, SVP, Retina. Why Retina Practices Must Demand Transparency, Flexibility, and True Value from Their Distributors The Illusion of a “Good Deal” Specialty distribution in retina care is riddled with complex pricing models and vague value...
